Encompass Health Corporation
EHC | NYSE
$136.84
+$0.94 (+0.69%)
Nov 2, 2026, 12:03 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 5.94B | 5.37B | 4.8B | 4.35B | 4.01B | 3.57B |
Cost of Revenue | 3.37B | 3.14B | 2.82B | 2.6B | 2.31B | 171M |
Gross Profit | 2.56B | 2.23B | 1.98B | 1.75B | 1.7B | 3.4B |
Operating Income | 1.05B | 864.5M | 731.8M | 630.2M | 659.4M | n/a |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 953M | 749.6M | 607.2M | 450.8M | 505M | 352.9M |
Net Income | 566.2M | 455.7M | 352M | 271M | 412.2M | 284.2M |
Selling & General & Admin | 295.2M | 266.5M | 258M | 209M | 228.5M | 2.12B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 1.22B | 1.1B | 993M | 914M | 815.5M | 1.28B |
Operating Expenses | 1.51B | 1.37B | 1.25B | 1.12B | 1.04B | 3.4B |
Interest Expense | 123.2M | 137.4M | 143.5M | 175.7M | 164.3M | 183.7M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.88B | 4.51B | 4.07B | 3.72B | 3.36B | 3.57B |
Income Tax Expense | 192.9M | 150.2M | 132.2M | 100.1M | 101.9M | 74.7M |
Shares Outstanding (Basic) | 100.5M | 99.9M | 99.5M | 99.2M | 99M | 98.6M |
Shares Outstanding (Diluted) | 102.2M | 102.2M | 101.3M | 100.4M | 100.2M | 99.8M |
EPS (Basic) | 5.62 | 4.53 | 3.54 | 2.72 | 4.15 | 2.87 |
EPS (Diluted) | 5.54 | 4.46 | 3.47 | 2.70 | 4.11 | 2.85 |
EBITDA | 1.4B | 1.19B | 1.02B | 870.1M | 888.9M | 739.6M |
EBIT | 1.08B | 887M | 750.7M | 626.5M | 669.3M | 536.6M |
Depreciation & Amortization | 327.9M | 299.6M | 273.9M | 243.6M | 219.6M | 203M |
Add to Watchlist
Select watchlists to add or remove EHC